Atossa Therapeutics, Inc. (GETTEX:YAG) Financings
Financings
| Raise | Date |
|---|---|
| Registered direct offering of common stock (or common stock equivalents) with Series A and Series B warrants Closed: US$4.5M raised · Series A and Series B warrants exercisable six months after issuance; Series A expire… · Rodman & Renshaw LLC Dealers: Rodman & Renshaw LLC (lead) Use of proceeds: Clinical development of product candidates, working capital and general corporate purposes | Jun 12, 2026 |